Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Shares Outstanding (Weighted Average) (2021 - 2025)

Tenon Medical has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $7384.0 for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 508.24% year-over-year to $7384.0; the TTM value through Dec 2025 reached $7384.0, up 508.24%, while the annual FY2025 figure was $7384.0, 508.24% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $7384.0 at Tenon Medical, down from $8250.0 in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $830000.0 in Q1 2021 and troughed at $197.0 in Q3 2023.
  • A 5-year average of $56490.2 and a median of $1057.0 in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 99.88% in 2022 and later soared 131054.31% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $903.0 in 2021, then fell by 11.3% to $801.0 in 2022, then tumbled by 71.66% to $227.0 in 2023, then soared by 434.8% to $1214.0 in 2024, then skyrocketed by 508.24% to $7384.0 in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for TNON at $7384.0 in Q4 2025, $8250.0 in Q3 2025, and $7591.0 in Q2 2025.